Mediclin Stock

Mediclin Equity

The The Equity of Mediclin (MED.DE) as of Mar 12, 2026 is 222.51 M EUR. In the previous year, The Equity was 195.92 M EUR — a change of 13.57% (higher).

Equity

222.51 MEUR

YoY

13.57%

Last updated: Mar 12, 2026

In 2026, Mediclin's equity was 222.51 M EUR, a 13.57% increase from the 195.92 M EUR equity in the previous year.

API Docs Get API Key

Mediclin Stock analysis

What does Mediclin do? Mediclin AG is a German company specializing in the care and treatment of patients. It was founded in 1984 in Berlin and has since relocated its headquarters to Offenburg. Mediclin operates over 50 healthcare facilities throughout Germany, including hospitals, rehabilitation centers, nursing facilities, and medical care centers. The company employs approximately 10,000 employees and generated a revenue of 1.17 billion euros in 2020. Mediclin is one of the most popular companies on Eulerpool.com.

Equity Details

Analyzing Mediclin's Equity

Mediclin's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Mediclin's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Mediclin's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Mediclin's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Mediclin’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Mediclin stock

The Equity of Mediclin amounted to 195.92 M EUR 222.51 M

Balance Sheet — Mediclin

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

All Key Metrics — Mediclin